Navigation Links
OTC Industry Announces Voluntary Transition to One Concentration of Single-Ingredient Pediatric Liquid Acetaminophen Medicines
Date:5/5/2011

ts. Consumers should always read and follow the label and pay particular attention to the concentration, especially when a healthcare provider gives dosing instructions.

The single-concentration liquid medicines will have additional enhancements to their age-appropriate dosing devices. Specifically, infants' products will have syringes for more accurate dosing and flow restrictors. Children's products, for ages two to under 12-years-old, will continue to offer dosing cups.

Acetaminophen is the most commonly used children's medicine for relieving pain and reducing fever. It provides parents and caregivers with an important doctor-recommended treatment option for relieving pain and fever in children when used as labeled.

More information is available at www.chpa-info.org.

CHPA is the 130-year-old-trade association representing U.S. manufacturers and distributors of over-the-counter medicines and nutritional supplements.

chpa-info.org


'/>"/>
SOURCE Consumer Healthcare Products Association
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cetero Research Names 25-Year Industry Veteran James Dixon to Head Quality and Compliance
2. Reportlinker Adds Pharmaceutical Key Trends 2011 - Pharmaceutical Industry Infrastructure Overview: Pharma innovates, diversifies and contains cost in order to grow profits
3. Top Three Healthcare Supply Chain Executives Challenge Industry
4. Medical Device Industry Veteran Angela Horacek Joins AlloSource as VP of Operations
5. Awarepoint to Showcase Industry-leading Real-time Location System (RTLS) at AONE Annual Meeting
6. Pacira Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
7. Reportlinker Adds Global: Pharmaceuticals Industry Guide
8. Avanir Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
9. FDA to Address Industry Questions About Biosimilar Regulations at the Pharmas IQ Immunogenicity Event
10. Reportlinker Adds Top 500 Pharmaceuticals Industry Report (Global)
11. Reportlinker Adds Top 200 Biopharmaceuticals Industry Report (Global)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 2014  RXi Pharmaceuticals Corporation (NASDAQ: ... developing and commercializing innovative therapies addressing major unmet ... enrollment in its first Phase 2a study, RXI-109-1301.  ... the 1-month findings that were reported in September ... http://photos.prnewswire.com/prnh/20130917/NE80755LOGO , , , ...
(Date:12/15/2014)... Research and Markets ( http://www.researchandmarkets.com/research/vt6973/mems_gyroscopes ... "MEMS Gyroscopes Analog Devices ADIS16136 Precision Angular Rate ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... made a lot of progress in the past ... now accepted in high-reliability environments, and are even ...
(Date:12/15/2014)... BerGenBio AS, a biopharmaceutical company ... cancers, today announces that it has raised NOK90 million ... and existing investors. BerGenBio will use the ... its pipeline of innovative cancer therapeutics, in particular an ... BGB324, a first-in-class selective Axl kinase inhibitor, which is ...
Breaking Medicine Technology:RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5MEMS Gyroscopes Analog Devices ADIS16136 Precision Angular Rate Sensor Reverse Costing Analysis 2BerGenBio Completes NOK90 Million Fundraising 2
... , THOUSAND OAKS, Calif., Sept. 21 ... from a Phase 3 trial evaluating denosumab administered subcutaneously versus ... treatment of bone metastases in 1,776 advanced cancer patients with ... myeloma. These results were presented today at the 2009 ...
... MADISON, Conn., Sept 18 Further results from the initial clinical ... treatment for varicose veins, will be delivered on Friday, September 25, ... Philadelphia. The device combines mechanical and chemical modalities to accomplish vein ... is Steve Elias MD FACS FACPh, Associate Professor of Surgery at ...
Cached Medicine Technology:Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases 2Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases 3Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases 4Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases 5Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases 6Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases 7Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases 8Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases 9ClariVein(TM) Catheter for Varicose Veins: Further Clinical Trial Results to Be Presented 2
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... of bird flu had been discovered in a Farm in ... cull thousands more, South Korea’s Farm// Ministry officials said on ... Kim Chang-sub, a top official at the Ministry’s Quarantine department ... avian influenza.' Kim also added that the final results of ...
... a new vaccine that promises protection against a wide range ... using a cell-based technology in 11 weeks time.The vaccine is ... H5N1 virus. ,It is still in the early phase of ... been detected in many countries. It has caused maximum damage ...
... Group (World Against Toys Causing Harm), for the 34th time, ... title 'Most Dangerous Toys of 2006' to watch out for. ... James Swartz, an attorney and director of Boston-based WATCH, which ... toy shelves are potentially stocked with dangerous toys which may ...
... in childhood could face an increased risk of developing ... ,The traditional view has been that psychosis such ... most psychiatrists have believed that social factors cannot have ... new study by the Institute of Psychiatry here examined ...
... McKeith has been reprimanded by the Medicines and Healthcare Regulatory ... a license. The authority said there was a lack of ... the star of Channel 4’s You Are What You Eat, ... Formula Wild Pink for women and Fast Formula Horny for ...
... incident 2 years ago, four persons had to be hospitalized ... with an cosmetic product that was unlicensed. The injection contained ... the lethal dose for humans, reported by The Journal of ... toxin, botox, is used to smoothen out facial wrinkles by ...
Cached Medicine News:Health News:WATCH's 2006 List Of Ten Potentially - Dangerous Toys 2
... An external computer-enhanced microplate reader ... provides automated flexible and rapid ... for accurate and reliable photometric ... or without shaking before reading) ...
... a number of assay steps for ... simple to use benchtop device. The ... stand-alone device but also provides easy ... and standard add-on modules provide maximum ...
... AP-22 Micro Plate Processor is ... Automated Microplate Analyzer. It has been ... assigned area can be customised according ... Micro Plate Processor is able to ...
Grab one and go, One of the smallest handheld oximeters available, Datex-Ohmeda s TuffSat is the ideal spot-check solution for hospital, home care, transport, and EMS. TuffSat comes fully loaded wi...
Medicine Products: